The groundbreaking therapy of the medication represents a exciting development in the care of the condition. Different to existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide319123.mybloglicious.com/62001503/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment